Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 0 | 796 | 0 | 0 | 2 |
| Gross Profit | N/A | 796 | N/A | N/A | 2 |
| Operating Expenses | 2,199 | 1,964 | 2,295 | 693 | 707 |
| Operating Income | -2,995 | -1,168 | -2,295 | -693 | -705 |
| Interest Expense | 33 | 31 | 129 | 223 | 217 |
| Other Income | -785 | -88 | 115 | -28 | 125 |
| Pre-tax Income | -3,812 | -1,287 | -2,309 | -944 | -797 |
| Income Tax | N/A | 1 | 24 | N/A | 0 |
| Net Income Continuous | -3,812 | -1,288 | -2,333 | -944 | -797 |
| Minority Interests | -250 | -41 | -76 | -102 | -65 |
| Net Income | $-3,563 | $-1,247 | $-2,257 | $-842 | $-732 |
| EPS Basic Total Ops | -0.15 | -0.05 | -0.13 | -0.06 | -0.02 |
| EPS Basic Continuous Ops | -0.16 | -0.06 | -0.13 | -0.06 | -0.02 |
| EPS Diluted Total Ops | -0.15 | -0.05 | -0.13 | -0.06 | -0.02 |
| EPS Diluted Continuous Ops | -0.16 | -0.06 | -0.13 | -0.06 | -0.02 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.05 | -0.13 | -0.06 | 0.04 |
| EBITDA(a) | $-1,985 | $-1,072 | $-2,214 | $-579 | $-827 |